CA
CTVA icon

Cullinan Associates’s Corteva CTVA Stock Holding History

Cullinan Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$424K Sell
5,007
-1,060
-17% -$85.1K 0.03% 162
2026
Q1 		$508K Buy
6,067
+200
+3% +$15.1K 0.04% 156
2025
Q4 		$393K Sell
5,867
-100
-2% -$6.46K 0.03% 174
2025
Q3 		$404K Buy
5,967
+115
+2% +$8.33K 0.03% 175
2025
Q2 		$436K Sell
5,852
-377
-6% -$25.1K 0.03% 175
2025
Q1 		$392K Sell
6,229
-930
-13% -$57.5K 0.03% 180
2024
Q4 		$408K Sell
7,159
-10,600
-60% -$627K 0.03% 177
2024
Q3 		$1.05M Sell
17,759
-7,110
-29% -$388K 0.06% 136
2024
Q2 		$1.34M Sell
24,869
-3,380
-12% -$186K 0.08% 129
2024
Q1 		$1.63M Sell
28,249
-150,120
-84% -$7.75M 0.09% 128
2023
Q4 		$8.55M Sell
178,369
-18,564
-9% -$885K 0.48% 49
2023
Q3 		$10.1M Sell
196,933
-4,035
-2% -$214K 0.59% 42
2023
Q2 		$11.5M Sell
200,968
-19,560
-9% -$1.14M 0.63% 42
2023
Q1 		$13.3M Buy
220,528
+755
+0.3% +$46.1K 0.78% 35
2022
Q4 		$12.9M Sell
219,773
-4,955
-2% -$314K 0.72% 31
2022
Q3 		$12.8M Sell
224,728
-9,086
-4% -$530K 0.81% 33
2022
Q2 		$12.7M Buy
233,814
+1,205
+0.5% +$70K 0.77% 36
2022
Q1 		$13.4M Buy
232,609
+7,964
+4% +$407K 0.7% 42
2021
Q4 		$10.6M Buy
224,645
+19,747
+10% +$899K 0.54% 50
2021
Q3 		$8.62M Buy
204,898
+28,900
+16% +$1.25M 0.48% 59
2021
Q2 		$7.81M Buy
175,998
+54,591
+45% +$2.52M 0.44% 69
2021
Q1 		$5.66M Sell
121,407
-120,063
-50% -$5.31M 0.33% 85
2020
Q4 		$9.35M Sell
241,470
-6,661
-3% -$238K 0.56% 47
2020
Q3 		$7.15M Buy
248,131
+115,200
+87% +$3.24M 0.46% 53
2020
Q2 		$3.56M Buy
132,931
+19,067
+17% +$496K 0.25% 90
2020
Q1 		$2.68M Buy
113,864
+9,544
+9% +$262K 0.22% 92
2019
Q4 		$3.08M Buy
104,320
+22,425
+27% +$594K 0.21% 95
2019
Q3 		$2.29M Buy
81,895
+44,430
+119% +$1.28M 0.16% 107
2019
Q2 		$1.11M Buy
+37,465
New +$1.01M 0.08% 127

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Cullinan Associates's CTVA Position: Q2 2026 in Review

Cullinan Associates reduced its Corteva (CTVA) stake by 17% in Q2 2026, selling an estimated $85.1K and leaving 5,007 shares worth $424K. The position accounts for 0.03% of the portfolio, ranked #162.

Cullinan Associates first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $13.4M in Q1 2022. 1,494 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Cullinan Associates held 5,007 shares of Corteva worth $424K as of Q2 2026.
  • Cullinan Associates sold 1,060 Corteva shares in Q2 2026, an estimated $85.1K.
  • Corteva made up 0.03% of Cullinan Associates's portfolio in Q2 2026, its #162 holding.
  • Cullinan Associates first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
  • Cullinan Associates's Corteva position peaked at $13.4M in Q1 2022.
  • 1,494 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.